Még nem toboroz
Maximizing Quality of Life After Cancer Through Rehabilitation
NCT07622407· VA Office of Research and Development· Forrás
Még nem toboroz
Boosting Exercise Adherence in Knee Osteoarthritis
NCT07219732· VA Office of Research and Development· Forrás
Még nem toboroz
Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans
NCT06963970· VA Office of Research and Development· Forrás
Toboroz
Implementing Cognitive Behavioral Therapy for Insomnia (SWELL): Function QUERI 3.0
NCT07216261· VA Office of Research and Development· Forrás
Toboroz
Implementing a Group Physical Therapy Program for Veterans (GroupPT): Function QUERI 3.0
NCT07215572· VA Office of Research and Development· Forrás
Toboroz
Increasing Germline Genetic Testing for Patients With Cancer
NCT07307664· Josh Peterson· Forrás
Toboroz
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
NCT06931340· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Toboroz
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT06520098· 2. fázis· VA Office of Research and Development· Forrás
Toboroz
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT06995898· National Cancer Institute (NCI)· Forrás
Toboroz
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
NCT06616584· 2/3. fázis· SWOG Cancer Research Network· Forrás
Toboroz
Pharmacogenomic Informed Statin Prescribing
NCT06568601· VA Office of Research and Development· Forrás
Toboroz
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
NCT06498635· 3. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
NCT05563766· 2. fázis· VA Office of Research and Development· Forrás
Fut, nem toboroz
Telehealth-based Symptom Management for Veterans Treated With Selinexor
NCT06452446· Durham VA Medical Center· Forrás
Toboroz
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
NCT06096844· 3. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
NCT05931276· 3. fázis· VA Office of Research and Development· Forrás
Toboroz
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
NCT05946213· 3. fázis· NRG Oncology· Forrás
Toboroz
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
NCT05486572· VA Office of Research and Development· Forrás
Toboroz
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
NCT05618353· 4. fázis· VA Office of Research and Development· Forrás
Toboroz
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
NCT05642572· 2. fázis· SWOG Cancer Research Network· Forrás
Toboroz
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
NCT02915198· 4. fázis· VA Office of Research and Development· Forrás
Toboroz
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069· Alliance for Clinical Trials in Oncology· Forrás
Fut, nem toboroz
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
NCT05096663· 2/3. fázis· SWOG Cancer Research Network· Forrás
Toboroz
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NCT05080673· NRG Oncology· Forrás
Fut, nem toboroz
Screening for High Frequency Malignant Disease
NCT05117840· Guardant Health, Inc.· Forrás
Toboroz
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
NCT05028972· VA Office of Research and Development· Forrás
Fut, nem toboroz
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
NCT05050084· 3. fázis· NRG Oncology· Forrás
Fut, nem toboroz
Telehealth to Improve Functional Status and Quality of Life in Veterans With PAD
NCT05048979· VA Office of Research and Development· Forrás
Toboroz
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
NCT05011383· 2. fázis· VA Office of Research and Development· Forrás
Fut, nem toboroz
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
NCT04787744· 2/3. fázis· VA Office of Research and Development· Forrás
Fut, nem toboroz
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
NCT04625647· 2. fázis· SWOG Cancer Research Network· Forrás
Toboroz
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
NCT04269902· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
NCT04513717· 3. fázis· NRG Oncology· Forrás
Fut, nem toboroz
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
NCT04214262· 3. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
NCT04239573· ECOG-ACRIN Cancer Research Group· Forrás
Toboroz
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
NCT04267848· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
NCI COVID-19 in Cancer Patients, NCCAPS Study
NCT04387656· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
NCT04155034· 3. fázis· SWOG Cancer Research Network· Forrás
Fut, nem toboroz
Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)
NCT04268550· 2. fázis· SWOG Cancer Research Network· Forrás
Fut, nem toboroz
A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
NCT04104893· 2. fázis· VA Office of Research and Development· Forrás
Fut, nem toboroz
Pentoxifylline in Diabetic Kidney Disease
NCT03625648· 4. fázis· VA Office of Research and Development· Forrás
Fut, nem toboroz
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT04094688· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Toboroz
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
NCT04038502· 2. fázis· VA Office of Research and Development· Forrás
Fut, nem toboroz
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
NCT03793166· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
NCT03793179· 3. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
NCT03851445· 2/3. fázis· SWOG Cancer Research Network· Forrás
Fut, nem toboroz
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
NCT03367702· 3. fázis· NRG Oncology· Forrás
Toboroz
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
NCT03151629· Prostate Cancer Clinical Trials Consortium· Forrás
Toboroz
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
NCT02984761· VA Office of Research and Development· Forrás
Fut, nem toboroz
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
NCT03108456· Abbott Medical Devices· Forrás
Showing 50 of 54.